Inventor
DIETZ LISA
DE18 patents
⚠️ This page may combine multiple inventors who share the name “DIETZ LISA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
11 patentsUS11478554B2Oct 25, 2022
Antibody drug conjugates (ADCS) having enzymatically cleavable groups
Bayer Pharma AG5 citations82
US11660351B2May 30, 2023
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
Bayer Pharma AG5 citations73
US9422285B2Aug 23, 2016
Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof
Bayer Pharma AG4 citations72
US11685714B2Jun 27, 2023
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
Bayer Pharma AG3 citations71
US11071788B2Jul 27, 2021
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
Bayer Pharma AG6 citations70
US10150773B2Dec 11, 2018
N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases
Bayer Pharma AG3 citations70
US11433140B2Sep 6, 2022
Specific antibody drug conjugates (ADCs) having KSP inhibitors
Bayer Pharma AG0 citations50
US10214526B2Feb 26, 2019
Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
Bayer Pharma AG0 citations49
US10292970B2May 21, 2019
Heteroaryl-substituted imidazo[1,2-A]pyridines and their use
Bayer Pharma AG0 citations41
US10174021B2Jan 8, 2019
Substituted pyrazolo[1,5-A]pyridines and their use
Bayer Pharma AG0 citations41
US9771360B2Sep 26, 2017
Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use
Bayer Pharma AG0 citations41
BAYER AG
7 patentsUS12195448B2Jan 14, 2025
Substituted pyrazolo piperidine carboxylic acids
BAYER AG4 citations69
US12059472B2Aug 13, 2024
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
BAYER AG1 citations60
US12595247B2Apr 7, 2026
Substituted pyrazolo piperidine carboxylic acids
BAYER AG0 citations57
US12138256B2Nov 12, 2024
Treatment of cardiopulmonary disorders
BAYER AG0 citations54
US12540134B2Feb 3, 2026
Inhibitors of adrenoreceptor ADRAC2
BAYER AG0 citations49
US11149018B2Oct 19, 2021
Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof
BAYER AG0 citations47
US11136296B2Oct 5, 2021
Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof
BAYER AG0 citations47